Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 25, Issue 5

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 25, Issue 5 (2016)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 25, Issue 5 (2016)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Volume 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Immunological and pleiotropic effects of individual β-blockers and their relevance in cancer therapies

Jinhyuk Fred Chung, Sang Joon Lee & Anil K. Sood

Pages: 501-505

Published online: 22 Mar 2016

First Page PreviewforImmunological and pleiotropic effects of individual β-blockers and their relevance in cancer therapies | Full Text | References | PDF (484 KB)

3107 Views
10 CrossRef citations
0Altmetric

Free Access

Review

Novel anti-angiogenic therapeutic strategies in colorectal cancer

M. Tampellini, C. Sonetto & G. V. Scagliotti

Pages: 507-520

Published online: 24 Mar 2016

AbstractforNovel anti-angiogenic therapeutic strategies in colorectal cancer | Full Text | References | PDF (1.4 MB)

1113 Views
52 CrossRef citations
0Altmetric

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC)

Yao-Chi Chuang, Christopher Chermansky, Mahendra Kashyap & Pradeep Tyagi

Pages: 521-529

Published online: 22 Mar 2016

AbstractforInvestigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC) | Full Text | References | PDF (846 KB)

828 Views
21 CrossRef citations
0Altmetric

Therapies in early development for the treatment of urinary tract inflammation

Martino Maria Zacchè & Ilias Giarenis

Pages: 531-540

Published online: 24 Mar 2016

AbstractforTherapies in early development for the treatment of urinary tract inflammation | Full Text | References | PDF (721.8 KB)

271 Views
14 CrossRef citations
0Altmetric

Therapies on the horizon for Clostridium difficile infections

Lynne V. McFarland

Pages: 541-555

Published online: 21 Mar 2016

AbstractforTherapies on the horizon for Clostridium difficile infections | Full Text | References | PDF (1.3 MB)

520 Views
20 CrossRef citations
0Altmetric

Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development

Ivan Gentile, Riccardo Scotto, Emanuela Zappulo, Antonio Riccardo Buonomo, Biagio Pinchera & Guglielmo Borgia

Pages: 557-572

Published online: 21 Mar 2016

AbstractforInvestigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development | Full Text | References | PDF (1.1 MB)

514 Views
15 CrossRef citations
0Altmetric

Drugs in early clinical development for Systemic Lupus Erythematosus

Mariana Postal, Nailú Angélica Sinicato, Simone Appenzeller & Timothy B. Niewold

Pages: 573-583

Published online: 07 Apr 2016

AbstractforDrugs in early clinical development for Systemic Lupus Erythematosus | Full Text | References | PDF (837.5 KB)

514 Views
10 CrossRef citations
0Altmetric

Investigational drugs for fracture healing: preclinical & clinical data

Michail E. Klontzas, Eustathios I. Kenanidis, Robert J. MacFarlane, Theodoros Michail, Michael E. Potoupnis, Manolis Heliotis, Athanasios Mantalaris & Eleftherios Tsiridis

Pages: 585-596

Published online: 28 Mar 2016

AbstractforInvestigational drugs for fracture healing: preclinical & clinical data | Full Text | References | PDF (1.1 MB)

566 Views
25 CrossRef citations
0Altmetric

Drug Evaluation

Article

Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer

S. Percy Ivy, Joyce F. Liu, Jung-Min Lee, Ursula A. Matulonis & Elise C. Kohn

Pages: 597-611

Published online: 16 Mar 2016

AbstractforCediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer | Full Text | References | PDF (1.8 MB)

1247 Views
34 CrossRef citations
0Altmetric

Article

Ixabepilone for the treatment of endometrial cancer

Claudia Marchetti, Ilaria Piacenti, Ludovica Imperiale, Francesca De Felice, Serena Boccia, Violante Di Donato, Giorgia Perniola, Marco Monti, Innocenza Palaia, Ludovico Muzii & Pierluigi Benedetti Panici

Pages: 613-618

Published online: 24 Mar 2016

AbstractforIxabepilone for the treatment of endometrial cancer | Full Text | References | PDF (515.5 KB)

180 Views
7 CrossRef citations
0Altmetric

Article

Celecoxib for the treatment of atherosclerosis

Nikolaos Papageorgiou, Effimia Zacharia, Alexandros Briasoulis, Marietta Charakida & Dimitris Tousoulis

Pages: 619-633

Published online: 21 Mar 2016

AbstractforCelecoxib for the treatment of atherosclerosis | Full Text | References | PDF (1.2 MB)

381 Views
15 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 21 Jun 2024

Free Access

Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs

Lorenza Magagnoli et al.

Review Article | Published online: 19 Jun 2024

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.25, Iss.5, 2016)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?